| 2023-06-26 |
详情>>
内部人交易：
KIRSKE DAVID等共交易8笔
|
| 2023-06-24 |
复牌提示：
2023-06-23 19:50:00 停牌，复牌日期 2023-06-27 00:00:01
|
| 2023-05-15 |
详情>>
股本变动：
变动后总股本13188.02万股
|
| 2023-05-15 |
详情>>
业绩披露：
2023年一季报每股收益-0.1美元,归母净利润-1342.2万美元,同比去年增长63.90%
|
| 2023-05-11 |
财报披露：
美东时间 2023-05-11 盘后发布财报
|
| 2023-04-28 |
股东大会：
将于2023-06-21召开股东大会
会议内容 ▼▲
- 1.To elect as directors the seven nominees named in the proxy statement to serve until the 2024 annual meeting of stockholders or until their successors are duly qualified and elected;
2.To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm;
3.To approve, by non-binding advisory vote, the compensation of our named executive officers;
4.To conduct an advisory vote to determine the frequency of holding future advisory votes on executive compensation;
5.To transact such other business as may properly come before the meeting and all adjournments and postponements thereof.
|
| 2023-03-06 |
详情>>
业绩披露：
2022年年报每股收益-0.81美元,归母净利润-9299.2万美元,同比去年增长5.02%
|
| 2022-11-07 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-0.69美元,归母净利润-7553.4万美元,同比去年增长-23.58%
|
| 2022-08-08 |
详情>>
业绩披露：
2022年中报每股收益-0.57美元,归母净利润-5982.9万美元,同比去年增长-61.96%
|
| 2022-05-12 |
详情>>
业绩披露：
2022年一季报每股收益-0.37美元,归母净利润-3717.5万美元,同比去年增长-115.31%
|
| 2022-04-19 |
股东大会：
将于2022-06-01召开股东大会
会议内容 ▼▲
- 1.To elect as directors the seven nominees named in the proxy statement to serve until the 2023 annual meeting of stockholders or until their successors are duly qualified and elected;
2.To approve the amendment and restatement of our 2017 Equity Incentive Plan to increase the shares available for issuance;
3.To approve the amendment and restatement of our 2007 Employee Stock Purchase Plan to increase the shares available for issuance;
4.To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm;
5.To approve, by non-binding advisory vote, the compensation of our named executive officers;
6.To transact such other business as may properly come before the meeting and all adjournments and postponements thereof.
|
| 2022-03-31 |
详情>>
业绩披露：
2021年年报每股收益-1.09美元,归母净利润-9790.8万美元,同比去年增长-86.67%
|
| 2021-11-12 |
详情>>
业绩披露：
2021年三季报(累计)每股收益-0.7美元,归母净利润-6112万美元,同比去年增长-63.21%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-05 |
详情>>
业绩披露：
2021年中报每股收益-0.44美元,归母净利润-3694.1万美元,同比去年增长-41.07%
|
| 2021-05-06 |
详情>>
业绩披露：
2021年一季报每股收益-0.23美元,归母净利润-1726.6万美元,同比去年增长-41.69%
|
| 2021-04-20 |
股东大会：
将于2021-06-02召开股东大会
会议内容 ▼▲
- 1.To elect as directors the six nominees named in the proxy statement to serve until the 2022 annual meeting of stockholders or until their successors are duly qualified and elected;
2.To approve an amendment to our certificate of incorporation to increase the total number of authorized shares of our common stock from 166,500,000 to 266,500,000;
3.To approve the amendment and restatement of our 2017 Equity Incentive Plan to increase the shares available for issuance;
4.To approve the amendment and restatement of our 2007 Employee Stock Purchase Plan, including to increase the shares available for issuance;
5.To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm;
6.To approve, by non-binding advisory vote, the compensation of our named executive officers;
7.To approve the adjournment of the meeting, if necessary or appropriate, to solicit additional proxies;
8.To transact such other business as may properly come before the meeting and all adjournments and postponements thereof.
|
| 2021-03-17 |
详情>>
业绩披露：
2020年年报每股收益-0.74美元,归母净利润-5245.1万美元,同比去年增长-31.06%
|
| 2020-04-23 |
股东大会：
将于2020-06-05召开股东大会
会议内容 ▼▲
- 1.To elect as directors the six nominees named in the proxy statement to serve until the 2021 annual meeting of stockholders or until their successors are duly qualified and elected;
2.To approve an amendment to our certificate of incorporation to increase the total number of authorized shares from 131,533,333 to 166,533,333 and to increase the total number of authorized shares of our common stock from 131,500,000 to 166,500,000;
3.To approve an increase of 5,100,000 shares reserved for issuance pursuant to our Amended and Restated 2017 Equity Incentive Plan;
4.To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2020;
5.To approve, by non-binding advisory vote, the compensation of our named executive officers;
6.To approve the adjournment of the meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the meeting to adopt any of the foregoing proposals;
7.To transact such other business as may properly come before the meeting and all adjournments and postponements thereof.
|
| 2019-04-04 |
股东大会：
将于2019-05-16召开股东大会
会议内容 ▼▲
- 1.To elect as directors the six nominees named in the proxy statement to serve until the 2020 annual meeting of stockholders or until their successors are duly qualified and elected;
2.To approve an amendment to our certificate of incorporation to increase the total number of authorized shares from 101,533,333 to 131,533,333 and to increase the total number of authorized shares of our common stock from 101,500,000 to 131,500,000;
3.To approve an increase of 2,000,000 shares reserved for issuance pursuant to our Amended and Restated 2017 Equity Incentive Plan;
4.To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2019;
5.To approve, by non-binding advisory vote, the compensation of our named executive officers;
6.To approve the adjournment of the meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the meeting to adopt any of the foregoing proposals;
7.To transact such other business as may properly come before the meeting and all adjournments and postponements thereof.
|
| 2018-03-30 |
股东大会：
将于2018-05-16召开股东大会
会议内容 ▼▲
- 1.To elect directors to the Company’s Board of Directors to serve one-year terms;
2.To approve an amendment to the Company’s Certificate of Incorporation to increase the total number of authorized shares from 81,533,333 to 101,533,333 and to increase the total number of authorized shares of our common stock from 81,500,000 to 101,500,000;
3.To approve the Company’s Amended and Restated 2017 Equity Incentive Plan to increase the share pool;
4.To ratify the selection of Marcum LLP as the Company’s independent auditor for the year ending December 31, 2018;
5.To approve, by non-binding advisory vote, the compensation of the Company’s named executive officers;
6.To approve the adjournment of the Annual Meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the Annual Meeting to adopt any of the foregoing items 1 through 5;
7.To transact such other business as may properly come before the Annual Meeting and all adjournments and postponements thereof.
|
| 2017-12-08 |
股东大会：
将于2018-01-24召开股东大会
会议内容 ▼▲
- 1.To approve the reincorporation of the Company from the State of Washington to the State of Delaware by merging the Company with and into a newly formed, wholly owned subsidiary;
2.To transact such other business as may properly come before the Special Meeting and all adjournments and postponements thereof.
|
| 2017-03-28 |
股东大会：
将于2017-05-16召开股东大会
会议内容 ▼▲
- 1.to elect directors to the Corporation’s Board to serve one-year terms;
2.to approve an amendment to the Corporation’s amended and restated articles of incorporation to increase the total number of authorized shares from 41,533,333 to 81,533,333 and to increase the total number of authorized shares of common stock from 41,500,000 to 81,500,000;
3.to approve the Corporation's 2017 Equity Incentive Plan having 2,500,000 shares available for issuance thereunder;
4.to ratify the selection of Marcum LLP as the Corporation’s independent auditors for the year ending December 31, 2017;
5.to approve, by non-binding advisory vote, the compensation of the Corporation’s named executive officers1;
6.to provide an advisory vote to determine whether an advisory vote on executive compensation should occur every one, two or three years;
7.to approve the adjournment of the Annual Meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the Annual Meeting to adopt any of Proposals 1 through 6;
8.to transact such other business as may properly come before the Annual Meeting and all adjournments and postponements thereof.
|
| 2016-12-09 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2016-03-17 |
股东大会：
将于2016-04-29召开股东大会
会议内容 ▼▲
- 1. to elect directors to the Corporation’s Board to serve one-year terms;
2. to approve an amendment to the Corporation’s amended and restated articles of incorporation to increase the total number of authorized shares from 315,333,333 to 415,333,333 and to increase the total number of authorized shares of common stock from 315,000,000 to 415,000,000;
3. to approve the adoption of the Corporation’s 2015 Equity Incentive Plan to increase the number of shares available for issuance thereunder by 18,000,000 shares;
4. to ratify the selection of Marcum LLP as the Corporation’s independent auditors for the year ending December 31, 2016;
5. to approve, by non-binding advisory vote, the compensation of the Corporation’s named executive officers;
6. to approve the adjournment of the Annual Meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the Annual Meeting to adopt any of Proposals 1 through 5;
7. to transact such other business as may properly come before the Annual Meeting and all adjournments and postponements thereof.
|
| 2015-07-29 |
股东大会：
将于2015-09-23召开股东大会
会议内容 ▼▲
- (1)To elect directors to the Company’s Board of Directors to serve one-year terms;
(2)To approve the Company’s 2015 Equity Incentive Plan;
(3)To approve an amendment to the Company’s 2007 Employee Stock Purchase Plan;
(4)To ratify the selection of Marcum LLP as the Company’s independent auditor for the year ending December 31, 2015;
(5)To approve, by non-binding advisory vote, the compensation of the Company’s named executive officers;
(6)To approve the adjournment of the Annual Meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the Annual Meeting to adopt any of Proposals 1 through 5;
(7)To transact such other business as may properly come before the Annual Meeting and all adjournments and postponements thereof.
|
| 2015-01-14 |
股东大会：
将于2015-02-27召开股东大会
会议内容 ▼▲
- 1. to approve an amendment to the Company’s amended and restated articles of incorporation to increase the total number of authorized shares from 215,333,333 to 315,333,333 and to increase the total number of authorized shares of common stock from 215,000,000 to 315,000,000 (“Proposal 1”);
2. to approve the adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to adopt Proposal 1 (“Proposal 2”);
3. to transact such other business as may properly come before the Special Meeting and all adjournments and postponements thereof.
|
| 2014-03-28 |
股东大会：
将于2014-05-22召开股东大会
会议内容 ▼▲
- 1. to approve an amendment to our Amended and Restated Articles of Incorporation, as amended (the “Articles”), to declassify our Board of Directors and provide for an annual election of all directors (“Proposal 1”);
2. if Proposal 1 is approved, to elect three directors to the Board of Directors to serve one-year terms, or if Proposal 1 is not approved, to elect three Class II directors to serve three-year terms (“Proposal 2”);
3. to approve an amendment to our 2007 Equity Incentive Plan, as amended and restated (the “2007 Equity Plan”), to increase the number of shares available for issuance thereunder by 11,000,000 shares (“Proposal 3”);
4. to ratify the selection of Marcum LLP as our independent auditors for the year ending December 31, 2014 (“Proposal 4”);
5. to approve, by non-binding advisory vote, the compensation of the Company’s named executive officers (“Proposal 5”);
6. to approve the adjournment of the Annual Meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the Annual Meeting to adopt any of Proposals 1 through 5 (“Proposal 6” and, collectively with Proposals 1 through 5, the “Proposals”);
7. to transact such other business as may properly come before the Annual Meeting and all adjournments and postponements thereof.
|